1. Home
  2. ACNB vs CTMX Comparison

ACNB vs CTMX Comparison

Compare ACNB & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACNB
  • CTMX
  • Stock Information
  • Founded
  • ACNB 1857
  • CTMX 2008
  • Country
  • ACNB United States
  • CTMX United States
  • Employees
  • ACNB N/A
  • CTMX N/A
  • Industry
  • ACNB Major Banks
  • CTMX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACNB Finance
  • CTMX Health Care
  • Exchange
  • ACNB Nasdaq
  • CTMX Nasdaq
  • Market Cap
  • ACNB 450.1M
  • CTMX 444.3M
  • IPO Year
  • ACNB N/A
  • CTMX 2015
  • Fundamental
  • Price
  • ACNB $45.50
  • CTMX $2.41
  • Analyst Decision
  • ACNB Strong Buy
  • CTMX Strong Buy
  • Analyst Count
  • ACNB 4
  • CTMX 2
  • Target Price
  • ACNB $50.00
  • CTMX $5.00
  • AVG Volume (30 Days)
  • ACNB 39.0K
  • CTMX 2.6M
  • Earning Date
  • ACNB 07-23-2025
  • CTMX 08-07-2025
  • Dividend Yield
  • ACNB 3.04%
  • CTMX N/A
  • EPS Growth
  • ACNB N/A
  • CTMX 128.27
  • EPS
  • ACNB 2.79
  • CTMX 0.49
  • Revenue
  • ACNB $113,448,000.00
  • CTMX $147,557,000.00
  • Revenue This Year
  • ACNB $38.67
  • CTMX N/A
  • Revenue Next Year
  • ACNB $5.26
  • CTMX N/A
  • P/E Ratio
  • ACNB $16.01
  • CTMX $5.15
  • Revenue Growth
  • ACNB 8.66
  • CTMX 23.81
  • 52 Week Low
  • ACNB $32.51
  • CTMX $0.40
  • 52 Week High
  • ACNB $50.72
  • CTMX $3.10
  • Technical
  • Relative Strength Index (RSI)
  • ACNB 67.09
  • CTMX 57.13
  • Support Level
  • ACNB $40.71
  • CTMX $2.15
  • Resistance Level
  • ACNB $44.53
  • CTMX $2.44
  • Average True Range (ATR)
  • ACNB 1.08
  • CTMX 0.22
  • MACD
  • ACNB 0.35
  • CTMX -0.03
  • Stochastic Oscillator
  • ACNB 91.52
  • CTMX 41.67

About ACNB ACNB Corporation

ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: